Healthcare
Live Price
Offline$0.001
+0.00% today
1Y Change
-99.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Telesis Bio, Inc. (TBIO) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 99.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +0.3%, EPS growth of +3.6%, a dividend yield of 0.0%. What stands out right now is revenue +0.3%, EPS +3.6%, free cash flow +15.1% with operating margin -169.2% and ROIC -72.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Stock Foundry combines TBIO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TBIO
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TBIO Max Drawdown
-99.97%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TBIO and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.